Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
ProShares UltraPro Russell2000
URTY
$335M
| $801K | ﹤0.01% |
+18,531
| New | +$810K |
|
2452
MediWound
MDWD
$183M
| $789K | ﹤0.01% |
50,844
-21,900
| -30% | -$362K |
|
2453
AerSale
ASLE
$307M
| $789K | ﹤0.01% |
114,000
-133,300
| -54% | -$954K |
|
2454
Prelude Therapeutics
PRLD
$350M
| $787K | ﹤0.01% |
206,600
-38,200
| -16% | -$155K |
|
2455
Byrna Technologies
BYRN
$111M
| $786K | ﹤0.01% |
+78,800
| New | +$972K |
|
|
IMA
2456
ImageneBio Inc
IMA
$64.2M
| $786K | ﹤0.01% |
39,700
-25,017
| -39% | -$442K |
|
2457
Smith Douglas Homes
SDHC
$124M
| $783K | ﹤0.01% |
33,500
+24,200
| +260% | +$648K |
|
2458
Heritage Global
HGBL
$36.5M
| $783K | ﹤0.01% |
318,217
-39,200
| -11% | -$94.7K |
|
|
SGMA
2459
DELISTED
Sigmatron International
SGMA
| $782K | ﹤0.01% |
139,887
+7,800
| +6% | +$35.7K |
|
2460
Zebra Technologies
ZBRA
$13.9B
| $782K | ﹤0.01% |
+2,531
| New | +$770K |
|
|
YMAB
2461
DELISTED
Y-mAbs Therapeutics
YMAB
| $781K | ﹤0.01% |
64,637
-50,663
| -44% | -$684K |
|
|
LITB
2462
LightInTheBox
LITB
$58.9M
| $781K | ﹤0.01% |
143,755
-3,917
| -3% | -$17.5K |
|
2463
iShares US Consumer Discretionary ETF
IYC
$1.21B
| $780K | ﹤0.01% |
9,600
-1,300
| -12% | -$103K |
|
2464
First Trust North American Energy Infrastructure Fund
EMLP
$4.13B
| $780K | ﹤0.01% |
25,600
-44,900
| -64% | -$1.35M |
|
2465
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.57B
| $780K | ﹤0.01% |
8,200
+200
| +3% | +$18.9K |
|
|
BLUE
2466
DELISTED
bluebird bio
BLUE
| $779K | ﹤0.01% |
39,575
-69,810
| -64% | -$1.4M |
|
2467
Rezolute
RZLT
$473M
| $776K | ﹤0.01% |
180,421
-149,660
| -45% | -$514K |
|
2468
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.79B
| $773K | ﹤0.01% |
27,300
-22,300
| -45% | -$632K |
|
2469
Scholar Rock
SRRK
$5.49B
| $769K | ﹤0.01% |
+92,364
| New | +$1.13M |
|
2470
Solitario Resources
XPL
$66.5M
| $769K | ﹤0.01% |
868,872
+86,854
| +11% | +$68.7K |
|
2471
iShares MSCI KLD 400 Social ETF
DSI
$5.43B
| $768K | ﹤0.01% |
7,400
-6,300
| -46% | -$630K |
|
2472
Mastech Digital
MHH
$95.4M
| $767K | ﹤0.01% |
102,327
-10,400
| -9% | -$86.5K |
|
2473
National CineMedia
NCMI
$392M
| $766K | ﹤0.01% |
174,400
-12,600
| -7% | -$60.8K |
|
2474
CNO Financial Group
CNO
$5.16B
| $765K | ﹤0.01% |
+27,600
| New | +$753K |
|
2475
First Bank
FRBA
$471M
| $763K | ﹤0.01% |
59,888
-900
| -1% | -$11K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.